| Glenmark Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532296 |
NSE Symbol : GLENMARK |
P/E(TTM) : 28.81 |
|
ISIN Demat : INE935A01035 |
Div & Yield% : 0.15 |
EPS(TTM) : 57.32 |
|
Book Value(₹) : 814.02 |
Market Cap(₹Cr) : 46,593.50 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,296.88 | 2,077.13 | 1,304.16 | 2,170.40 | 2,098.06 | 1,874.97 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,296.88 | 2,077.13 | 1,304.16 | 2,170.40 | 2,098.06 | 1,874.97 |
| Other Operating Income | 32.66 | 71.09 | 60.93 | 63.01 | 46.32 | 64.08 |
| Other Income | 55.65 | 5,933.18 | 258.82 | 73.58 | 49.36 | 232.97 |
| Total Income | 2,385.19 | 8,081.41 | 1,623.91 | 2,306.99 | 2,193.75 | 2,172.01 |
| Total Expenditure | 1,698.44 | 1,650.78 | 1,574.65 | 1,809.60 | 1,691.02 | 2,379.75 |
| PBIDT | 686.75 | 6,430.63 | 49.26 | 497.40 | 502.73 | -207.74 |
| Interest | 15.35 | 83.39 | 73.60 | 58.19 | 61.93 | 58.86 |
| PBDT | 671.40 | 6,347.25 | -24.34 | 439.21 | 440.79 | -266.60 |
| Depreciation | 53.09 | 52.40 | 51.16 | 49.85 | 48.75 | 46.73 |
| Tax | 107.98 | 1,055.38 | -53.17 | 9.22 | 38.57 | 84.65 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 56.60 | 625.77 | -1.93 | 77.80 | 81.82 | -260.51 |
| Reported Profit After Tax | 453.73 | 4,613.70 | -20.41 | 302.35 | 271.66 | -137.47 |
| Extra-ordinary Items | 0.00 | 3,772.34 | -25.28 | -15.27 | -21.92 | -573.72 |
| Adjusted Profit After Extra-ordinary item | 453.73 | 841.36 | 4.87 | 317.62 | 293.58 | 436.25 |
| EPS (Unit Curr.) | 16.08 | 163.50 | -0.72 | 10.72 | 9.63 | -4.87 |
| EPS (Adj) (Unit Curr.) | 16.08 | 163.50 | -0.72 | 10.72 | 9.63 | -4.87 |
| Calculated EPS (Unit Curr.) | 16.08 | 163.50 | -0.72 | 10.72 | 9.63 | -4.87 |
| Calculated EPS (Adj) (Unit Curr.) | 16.08 | 163.50 | -0.72 | 10.72 | 9.63 | -4.87 |
| Calculated EPS (Ann.) (Unit Curr.) | 64.32 | 653.98 | -2.89 | 42.86 | 38.51 | -19.49 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 64.32 | 653.98 | -2.89 | 42.86 | 38.51 | -19.49 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 29.90 | 309.59 | 3.78 | 22.92 | 23.96 | -11.08 |
| PBDTM(%) | 29.23 | 305.58 | -1.87 | 20.24 | 21.01 | -14.22 |
| PATM(%) | 19.75 | 222.12 | -1.56 | 13.93 | 12.95 | -7.33 |